Immuno-Oncology

Latest Immuno-Oncology Videos

View all
3:15
Predictive biomarkers for RAS-wt mCRC treated with cetuximab and m-FOLFOXIRI
Yu Sunakawa • 21 Oct 2023
0:56
Elucidating the role of immunotherapy in pancreatic cancer
Akihiro Ohba • 22 Oct 2023
1:24
Highlights from SABCS 2023: novel agents and insights on HER2 dynamics in breast cancer
Kevin M. Kalinsky • 5 Dec 2023
1:09
Challenges in integrating exercise as a cancer treatment in clinical practice
Kerry S. Courneya • 5 Dec 2023

RECENT CONFERENCES

ASCO 2023
ESMO BREAST 2023
AACR 2023
ELCC 2023
GU Cancers 2023
0:50
Identifying patients with HNSCC that will respond to neoadjuvant immunotherapy
Charlotte Zuur • 4 Jun 2023
1:09
Clinical implications of neoadjuvant immunotherapy in CSCC
Charlotte Zuur • 4 Jun 2023
1:40
MATISSE: nivolumab in cutaneous squamous cell carcinoma
Charlotte Zuur • 4 Jun 2023
0:41
The role of targeted therapies in HER2+ and HR+ breast cancer
Yutaka Yamamoto • 4 Jun 2023
View All Videos
0:44
ADCs in early breast cancer
Sung-Bae Kim • 11 May 2023
1:23
Latest advances in immuno-oncology research in ER+ breast cancer
Justin Balko • 12 May 2023
0:55
Prognostic biomarkers of immunotherapy efficacy in breast cancer
Justin Balko • 12 May 2023
3:55
Is it possible to predict who will benefit the most from IO in TNBC?
Justin Balko • 12 May 2023
View All Videos
2:31
A brief background on neoantigen vaccines
Mansi Saxena • 16 Apr 2023
1:36
The future of arginine deprivation therapy in lung cancer
Peter Szlosarek • 18 Apr 2023
1:52
Enhancing the efficacy of immunotherapy in prostate cancer
Scott Tagawa • 16 Apr 2023
2:25
Phase I trial of ARX517, an anti-PSMA ADC, in mCRPC
Scott Tagawa • 16 Apr 2023
View All Videos
0:25
Anticipations for ELCC 2023
Milica Kontic Jovanovic • 27 Mar 2023
2:36
What is the risk of pneumonitis in patients with pulmonary fibrosis treated with ICIs?
Milica Kontic Jovanovic • 27 Mar 2023
1:33
Managing low-grade immunotherapy-associated toxicity in lung cancer
Milica Kontic Jovanovic • 27 Mar 2023
3:29
Novel strategies to treating brain metastases in lung cancer
Samreen Ahmed • 27 Mar 2023
View All Videos
1:27
Unmet needs regarding immunotherapy for renal cell carcinoma
Nazli Dizman • 24 Feb 2023
5:07
Association between time-of-day of ICI infusion and disease outcomes in metastatic RCC)
Nazli Dizman • 24 Feb 2023
1:21
KEYNOTE-921: pembrolizumab plus docetaxel in chemotherapy-naïve mCRPC
Daniel P. Petrylak • 16 Feb 2023
1:18
Updates from KEYNOTE-905: immunotherapy + cystectomy vs cystectomy alone in MIBC
Andrea Necchi • 18 Feb 2023
View All Videos

Breast Cancer

View all
1:24
Highlights from SABCS 2023: novel agents and insights on HER2 dynamics in breast cancer
Kevin M. Kalinsky • 5 Dec 2023
1:09
Challenges in integrating exercise as a cancer treatment in clinical practice
Kerry S. Courneya • 5 Dec 2023
0:59
Trastuzumab deruxtecan in patients with breast cancer with brain metastases
Janice Wing-Hang Tsang • 21 Oct 2023
1:07
NeoTRIP: EFS in neoadjuvant atezolizumab with taxane/carboplatin ± anthracycline in high-risk TNBC
Kevin Kalinsky • 22 Oct 2023

Lung Cancer

View all
1:34
Treatment guidelines for non-oncogene-addicted metastatic NSCLC
Marco Tagliamento • 23 Oct 2023
1:52
Lurbinectedin in combination with pembrolizumab in relapsed SCLC
Andrea Ardizzoni • 23 Oct 2023
2:36
Unexpected safety data in TREASURE: thoracic radiotherapy with atezolizumab in SCLC
Andrea Ardizzoni • 23 Oct 2023
0:52
LUPER: lurbinectedin in combination with pembrolizumab in relapsed SCLC
Antonio Calles Blanco • 22 Oct 2023

Genitourinary Cancer

View all
3:41
TIDE-A: avelumab and intermittent axitinib in metastatic renal cell carcinoma
Roberto Iacovelli • 23 Oct 2023
2:17
Will enfortumab vedotin and pembrolizumab be the new SOC in urothelial cancer?
Enrique Grande • 20 Nov 2023
1:20
Combining ADC’s with other novel agents in the frontline treatment of urothelial carcinoma
Andrea Necchi • 23 Oct 2023
1:54
Updates in the field of bladder cancer from ESMO 2023
Andrea Necchi • 23 Oct 2023
The content of VJOncology is intended for healthcare professionals